Fig. 1: Waterfall plots for patients enrolled on study. | British Journal of Cancer

Fig. 1: Waterfall plots for patients enrolled on study.

From: Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma

Fig. 1

There is objective tumour shrinkage in the majority of patient enrolled on study, although only five patients achieved partial response by RECIST 1.1 definition. Note that three patients without a 20% increase in the sum of target lesion diameters were classified as progressive disease based on the appearance of new lesions (identified by asterisks).

Back to article page